Chronic Kidney Disease and a 'Kidney-Strengthening' Herb List
Mrs. Okafor, 72, has stage 3b chronic kidney disease (eGFR 38 mL/min/1.73 m²), type 2 diabetes, and hypertension. She takes metformin, losartan, and furosemide. She asks for a Chinese herbal formula to 'strengthen her kidneys' because she has fatigue, lower back ache, and mild ankle edema. She brings a list of herbs she read about online: Mu Tong (Akebia quinata), Xi Xin (Asarum), Ze Xie, Huang Qi, and Dan Shen. She says a relative took Mu Tong for years without problems. She also reports occasional palpitations and takes a potassium supplement.
1. Evaluate the herb list for safety in this patient, identifying specific nephrotoxic, hyperkalemic, or interaction risks.
Read the worked answer
Mu Tong is unacceptable: some Akebia and aristolochic acid-containing sources cause aristolochic acid nephropathy and urothelial cancer, especially in CKD. Xi Xin (Asarum) may contain aristolochic acid and is nephrotoxic; avoid. Ze Xie is a diuretic that can alter potassium and fluid balance. Huang Qi may lower blood pressure and glucose and has immunomodulatory effects. Dan Shen is antiplatelet and may increase bleeding risk.
She already takes losartan, furosemide, and potassium supplements, so hyperkalemia is a major concern. Metformin requires caution at eGFR 38 and should be reviewed by her physician. The combination is unsafe without nephrology input.
2. Propose a monitoring plan and communication strategy with her nephrologist and pharmacist, including what you would not prescribe.
Read the worked answer
Do not prescribe Mu Tong, Xi Xin, or any Aristolochia species. Obtain baseline and follow-up basic metabolic panel, potassium, creatinine/eGFR, blood pressure, and glucose. Coordinate with her nephrologist and pharmacist before any herbal trial, and ask them to review metformin and potassium supplementation.
Provide a written list of proposed herbs and doses to the physician. Monitor for edema, palpitations, weakness, and bleeding. If potassium is elevated or renal function declines, stop herbs and refer. Document all communications and keep the patient informed.
3. If she insists on taking something, how would you apply informed consent and shared decision-making while staying within scope?
Read the worked answer
Explain the specific risks in her case, including kidney injury, hyperkalemia, bleeding, and drug interactions. Offer safer alternatives such as acupuncture, dietary counseling, physical therapy, and stress management. If she still wants herbal care, use shared decision-making: choose a minimal formula of low-risk herbs, start low, and require physician approval and laboratory monitoring.
Document her informed refusal of the safest option, the risks discussed, and the monitoring plan. Do not abandon her; schedule close follow-up. Stay within scope by not changing her prescription medications or promising to improve kidney function.